LivaNova PLC Appoints Thad Huston as Principal Accounting Officer, effective from May 19, 2020
May 19, 2020 at 07:38 am EDT
Share
On May 13, 2020, it was determined that Thad Huston, Chief Financial Officer of LivaNova PLC, would become the Company's Principal Accounting Officer, effective May 19, 2020, following the resignation of the Company's previous Principal Accounting Officer on May 15, 2020. Previous to his start at LivaNova as Chief Financial Officer on May 20, 2017.
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Companyâs next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.
LIVANOVA PLC 
